Fourteen-year experience of a tertiary hospital transfusion committee in West Africa

Transfusion

Volumn 54, Issue 11, 2014, Pages 2852-2862

  Opare Sem, Ohene ^a   Bedu Addo, George ^a   Karikari, Patrick ^a   Boateng, Peter ^a   Sarkodie, Francis ^a   Rahman, Rabiniatu ^a   Asenso Mensah, Kwame ^a   Awuah, Baffour ^a   Osei Akoto, Alex ^a   Munin, S A Abdul ^a   Mensah Acheampong, Fred ^a   Allain, Jean Pierre ^b   Owusu Ofori, Shirley ^a  

^a KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; DECISION MAKING; ENZYME IMMUNOASSAY; FEMALE; HEALTH CARE COST; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; REIMBURSEMENT; TERTIARY CARE CENTER; THROMBOCYTOPENIA; VASCULARIZATION; WEST AFRICAN; GHANA; MEDICAL AUDIT;

BLOOD TRANSFUSION; DECISION MAKING; FEMALE; GHANA; HUMANS; MALE; MEDICAL AUDIT; TERTIARY CARE CENTERS;

EID: 84912119348     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12690     Document Type: Article

References (50)

1. Grindon AJ, Tomasulo PS, Bergin JJ, et al. The hospital transfusion committee. Guidelines for improving practice. JAMA 1985; 253: 540-543.
2. Haynes SL, Torella F,. The role of hospital transfusion committee in blood product conservation. Transfus Med Rev 2004; 18: 93-104.
3. Popovsky MA,. The transfusion medicine consultant and hospital transfusion committee. Vox Sang 1998; 74 (Suppl 2): 391-393.
4. James RM, Brown S, Parapia LA, et al. The impact of a 10-year audit cycle on blood usage in a district general hospital. Transfus Med 2001; 11: 371-375.
5. Torella F, Haynes SL, Bennett J, et al. Can hospital transfusion committee change transfusion practice? J R Soc Med 2002; 95: 450-452.
6. Jackson GN, Snowden CA, Indrikovs AJ,. A prospective audit program to determine blood component transfusion appropriateness at a large university hospital: a 5-year experience. Transfus Med Rev 2008; 22: 154-161.
7. Shulman IA, Saxena S,. The transfusion services committee-responsibilities and response to adverse transfusion events. Hematology Am Soc Hematol Educ Program 2005: 483-490.
8. Lund TC, Hume H, Allain JP, et al. The blood supply in Sub-Saharan Africa: needs, challenges, and solutions. Transfus Apher Sci 2013; 49: 416-421.
9. Owusu-Ofori S, Temple J, Sarkodie F, et al. Pre-donation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion 2005; 45: 133-140.
10. Allain JP, Opare-Sem O, Sarkodie F, et al. Deferred donor care in a regional hospital blood center in Ghana. Transfusion 2009; 49: 669-675.
11. Allain JP, Smit-Sibinga CT,. Stigmatizing family donors impairs blood availability in developing countries. J Blood Transfus 2014; in press.
12. Allain JP, Sarkodie F, Asenso-Mensah K, et al. Relative safety of first-time volunteer and replacement donors in West Africa. Transfusion 2010; 50: 340-343.
13. Allain JP, Sarkodie F, Boateng P, et al. A pool of repeat blood donors can be generated with little expense to the blood center in Sub-Saharan Africa. Transfusion 2008; 48: 735-741.
14. Owusu-Ofori S, Asenso-Mensah K, Boateng P, et al. Fostering repeat donations in Ghana. Biologicals 2010; 38: 47-52.
15. Sarkodie F, Adarkwa M, Adu-Sarkodie Y, et al. Screening for viral markers in volunteer and replacement blood donors in West Africa. Vox Sang 2001; 80: 142-147.
16. Allain JP, Candotti D, Soldan K, et al. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 2003; 101: 2419-2425.
17. Candotti D, Temple J, Sarkodie F, et al. Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol 2003; 77: 7914-7923.
18. Candotti D, Sarkodie F, Allain JP,. Residual risk of HIV and HCV transmission by transfusion in Ghana. Br J Haematol 2001; 113: 37-39.
19. Allain JP,. Moving on from voluntary non-remunerated donors: who is the best donor? Br J Haematol 2011; 154: 763-769.
20. Loua A, Nze Nkoure G,. Relative safety of first-time volunteer and replacement donors in Guinea. Transfusion 2010; 50: 1851-1852.
21. Mbanya DN, Feunou F, Tayou TC,. Volunteer or family/replacement donations: are the tides changing? Transfusion 2010; 50: 1849-1850.
22. Diarra A, Kouriba B, Baby M, et al. HIV, HCV, HBV and syphilis rate of positive donations among blood donations in Mali: lower rates among volunteer blood donors. Transfus Clin Biol 2009; 16: 444-447.
23. Asenso-Mensah K, Achina G, Appiah R, et al. Can family or replacement blood donors become regular volunteer donors? Transfusion 2014; 54: 797-804.
24. Li C, Danso K, Addo-Yobo E, et al. GB virus C genotype 1 is rarely transmitted vertically but acquired during infancy in West Africa. AIDS 2006; 20: 1458-1459.
25. Parsyan A, Kerr S, Owusu-Ofori S, et al. Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from genotype 1 or 3 endemic areas. J Clin Microbiol 2006; 44: 1367-1375.
26. Wang W, Sarkodie F, Danso K, et al. Seroprevalence of west Nile virus in Ghana. Viral Immunol 2009; 22: 17-27.
27. Gobbini F, Owusu-Ofori S, Marcelin AG, et al. Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion 2012; 52: 2294-2299.
28. Owusu-Ofori AK, Parry CM, Bates I,. Transfusion-transmitted syphilis in teaching hospital, Ghana. Emerg Infect Dis 2011; 17: 2080-2082.
29. Freimanis G, Sedegah M, Owusu-Ofori S, et al. Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion 2013; 53: 1429-1441.
30. El Chaar M, Atwal S, Freimanis GL, et al. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion 2013; 53: 3174-3183.
31. Owusu-Ofori S, Owusu-Ofori A, Freimanis GL, et al. Riboflavin and UV illumination treatment of whole blood units (WBU) in a Ghanaian blood center [abstract]. Transfusion 2013; 53 Suppl 2: 202A.
32. Candotti D, Temple J, Owusu-Ofori S, et al. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1. J Virol Methods 2004; 118: 39-47.
33. Candotti D, Opare-Sem O, Rezvan H, et al. Molecular and serological characterization of hepatitis B virus in deferred Ghanaian blood donors with and without elevated alanine amino transferase. J Viral Hepat 2006; 13: 715-724.
34. Ala F, Allain JP, Bates I, et al. External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. Plos Med 2012; 9: e1001309.
35. Candotti D, Richetin A, Cant B, et al. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion 2003; 43: 215-225.
36. Parsyan A, Addo-Yobo E, Owusu-Ofori S, et al. Effects of transfusion on human erythrovirus B19 susceptible or infected pediatric recipients in a genotype 3 endemic area. Transfusion 2006; 46: 1593-1600.
37. Zahn A, Li C, Danso K, et al. Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol 2008; 89: 409-418.
38. Lefrère JJ, Allain JP, Prati D, et al. Blood and Organ Transmissible Infectious Agents (BOTIA) group. West Nile virus and blood donors. Lancet 2003; 361: 2083-2084.
39. Osei EN, Odoi AT, Owusu-Ofori S, et al. Appropriateness of blood product transfusion in the Obstetrics and Gynaecology (O&G) department of a tertiary hospital in West Africa. Transfus Med 2013; 23: 160-166.
40. Opare-Sem O, Owusu-Ofori S, Allain JP,. A novel approach to blood safety: pre-donation screening of blood donors for viral markers. Afr Sang 2002; 5: 12-16.
41. Kubio C, Tierney G, Quaye T, et al. Blood transfusion practice in a rural hospital in Northern Ghana, Damongo, West Gonja District. Transfusion 2012; 52: 2161-2166.
42. Okafor LA, Orhue A, Sahu BB,. Blood transfusion in obstetrics and gynaecology: pattern, problems and prospects. East Afr Med J 1986; 63: 63-66.
43. Bates I, Chapotera GK, McKew S, et al. Maternal mortality in sub-Saharan Africa: the contribution of ineffective blood transfusion services. BJOG 2008; 115: 1331-1339.
44. Natukunda B, Schonewille H, Smit Sibinga CT,. Assessment of the clinical transfusion practice at a regional referral hospital in Uganda. Transfus Med 2010; 20: 134-139.
45. Tapko JB, Toure B, Sambo LG,. Status of blood safety in the WHO African region. Report of the 2010 survey. Brazzaville, Democratic Republic of the Congo: WHO Regional Office for Africa; 2014.
46. Zervou EK, Ziciadis K, Karabini F, et al. Vasovagal reactions in blood donors during or immediately after blood donation. Transfus Med 2005; 15: 389-394.
47. Tondon R, Pandey P, Chaudhary R,. Vasovagal reactions in "at risk" donors: a univariate analysis of effect of age and weight on the grade of donor reactions. Transfus Apher Sci 2008; 39: 95-99.
48. Garozzo G, Crocco I, Giussani B, et al. Adverse reactions to blood donations: the READ project. Blood Transfus 2010; 8: 49-62.
49. Newman B,. Arm complications after manual whole blood donation and their impact. Transfus Med Rev 2013; 27: 44-49.
50. Goldman M, Osmond L, Yi QL, et al. Frequency and risk factors for donor reactions in an anonymous blood donor survey. Transfusion 2013; 53: 1979-1984.